While Johnson & Johnson retains the top revenue rank across the major pharma companies, Eli Lilly last year established ...

Nearly 96 percent of U.S. pharmaceutical sales were brought to the market through pharmaceutical distributors in 2016, according to a new report published by the HDA Research Foundation, a healthcare ...

William Blair on Monday initiated coverage on Eupraxia Pharmaceuticals Inc. EPRX, a clinical-stage biotechnology company ...

2025 might shape out to be a boon year for pharma, a recent report from Norstella’s Evaluate suggests. The 2025 Preview Report examines the “biggest movers and shakers” in the biotech and pharma ...

Q4 2025 Management View Richard Lowenthal, Co-Founder, President, CEO & Director, highlighted that "2025 was our first full year for ARS as a commercial company. It was a year focused on building ...

Ascentage Pharma reported 2024 sales of $134.3M, up 342% YoY, driven by a $100M option payment from Takeda under an exclusive agreement. JP Morgan initiated Ascentage Pharma with an Overweight rating ...

The primary growth drivers in Bayer’s pharma sector—Nubeqa and Kerendia—are performing even better than the company anticipated and their momentum is expected to continue in 2026. But that won’t lead ...

Evoke Pharma reported Q1 2025 net product sales of $3.1 million, a 77% increase from the previous year. Despite a significant increase in net product sales, the net loss remains substantial at ...

India's pharmaceutical market grew 11% in February 2026, driven by strong anti-diabetic, cardiac and anti-infective therapy ...

The latest announcement is out from Solasia Pharma KK ( (JP:4597)). Solasia Pharma K.K. has announced a change in its sales partner for the oral liquid product, episil, in China. The company is ...